Home/Filings/4/0001599901-25-000131
4//SEC Filing

Gallagher Kathleen P. 4

Accession 0001599901-25-000131

CIK 0001599901other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 6:02 PM ET

Size

5.0 KB

Accession

0001599901-25-000131

Insider Transaction Report

Form 4
Period: 2025-06-17
Gallagher Kathleen P.
Chief Program Officer
Transactions
  • Sale

    Common Stock

    2025-06-17$30.24/sh911$27,54950,392 total
Footnotes (1)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.

Issuer

Avidity Biosciences, Inc.

CIK 0001599901

Entity typeother

Related Parties

1
  • filerCIK 0002048409

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 6:02 PM ET
Size
5.0 KB